Roivant Sciences Ltd. · NASDAQ:ROIV
Fitzgerald Meghan sold 5,112 Roivant Sciences Ltd. shares (Form 4)
Traded Sep 15, 2026 · Filed Sep 17, 2026
On Sep 15, 2026, Fitzgerald Meghan (Director) sold 5,112 Roivant Sciences Ltd. shares at an average US$39.74 for US$203K under a trading plan, leaving 36,108 shares. Filed Sep 17, 2026 (Form 4).
- Sold
- 5,112 shares
- Price
- US$39.74 average (US$39.68 to US$40.45)
- Value
- US$203K
- Holding after
- 36,108 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Shares | Sale | 4,712 | US$39.68 | 36,508 | Direct |
| Sep 15, 2026 | Common Shares | Sale | 400 | US$40.45 | 36,108 | Direct |
Source
Related
- Roivant Sciences Ltd.
- Fitzgerald Meghan
- Roivant Sciences Ltd. shareholders
- Form 4 · Fitzgerald Meghan · Sep 18, 2026
- Form 4 · Fitzgerald Meghan · Sep 14, 2026
- Form 4 · Fitzgerald Meghan · Sep 10, 2026
- Form 4 · Fitzgerald Meghan · Jul 2, 2026
- Form 4 · Sukhatme Mayukh · Oct 20, 2026
- Form 4 · Gline Matthew · Oct 20, 2026
- Form 4 · Epperly Melissa B, · Oct 5, 2026
- Form 4 · Venker Eric · Oct 2, 2026
- Form 4 · Torti Frank · Oct 2, 2026